![Frederick John Livesey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Frederick John Livesey
Fondatore presso Talisman Therapeutics Ltd.
Profilo
Frederick John Livesey was the founder of Gen2 Neuroscience Ltd.
where he held the title of Chief Executive Officer.
Dr. Livesey is also the founder of Talisman Therapeutics Ltd.
Posizioni attive di Frederick John Livesey
Società | Posizione | Inizio |
---|---|---|
Talisman Therapeutics Ltd.
![]() Talisman Therapeutics Ltd. BiotechnologyHealth Technology Talisman Therapeutics Ltd. is a human stem cell research and development company. The firm is committed for revolutionizing the discovery of treatments for Alzheimer’s disease. The company is headquartered in Cambridge, the United Kingdom. | Fondatore | - |
Precedenti posizioni note di Frederick John Livesey
Società | Posizione | Fine |
---|---|---|
Gen2 Neuroscience Ltd.
![]() Gen2 Neuroscience Ltd. Pharmaceuticals: GenericHealth Technology Gen2 Neuroscience Ltd. develops novel treatments for dementia targeting abnormal forms of the essential cellular protein tau. The company was founded by Frederick John Livesey in January 07, 2016 and is headquartered in Manchester, the United Kingdom. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Gen2 Neuroscience Ltd.
![]() Gen2 Neuroscience Ltd. Pharmaceuticals: GenericHealth Technology Gen2 Neuroscience Ltd. develops novel treatments for dementia targeting abnormal forms of the essential cellular protein tau. The company was founded by Frederick John Livesey in January 07, 2016 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Talisman Therapeutics Ltd.
![]() Talisman Therapeutics Ltd. BiotechnologyHealth Technology Talisman Therapeutics Ltd. is a human stem cell research and development company. The firm is committed for revolutionizing the discovery of treatments for Alzheimer’s disease. The company is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Frederick John Livesey